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of primary and secondary patency and number of revisions. AAssessment of a policy to reduce placement of prosthetic hemo-
policy emphasizing the preferential placement of autogenousdialysis access.
fistulas over prosthetic grafts may result in improved patencyBackground. The aim of this study was to evaluate the deter-
and a reduction in the number of procedures required to main-minants of access patency and revision, including the effects
tain dialysis access patency.of reducing the placement of prosthetic hemodialysis access.
Methods. A retrospective cohort study of all hemodialysis
accesses placed at the Veteran’s Administration Puget Sound
Health Care System between 1992 and 1999 was conducted.
The creation and maintenance of dialysis access forA policy was instituted in 1996 that maximized the use of
long-term hemodialysis have assumed increasing impor-autogenous hemodialysis access. The impacts of the policy
change, demographics, and comorbid factors on access type tance as the number of patients with end-stage renal
and patency, were examined. Primary and secondary patency disease (ESRD) in the United States has increased. Ac-
rates were examined using the Kaplan–Meier method, and cording to the most recent United States Renal Datafactors associated with failure and revision were examined
System annual report, there are approximately 264,000using Cox proportional hazard models and Poisson regression.
patients in the United States who require chronic hemo-Results. During the study, 104 accesses (61 prosthetic grafts
and 43 autogenous fistulas) were placed prior to 1996, and 118 dialysis. In 1997, Medicare reimbursement to physicians
(31 prosthetic grafts and 87 autogenous fistulas) were placed for placement and maintenance of dialysis access was
after 1996. There was a significant increase in autogenous fistu- $127 million [1]. Up to 25% of all hospital stays amonglas placed after 1996 (87 out of 118) compared with before
patients with ESRD are related to placement of or mor-1996 (43 out of 104, P , 0.001). At one year, autogenous
bidity associated with dialysis access [2]. The impact offistulas demonstrated superior primary patency (56 vs. 36%,
P 5 0.001) and secondary patency (72 vs. 58%, P 5 0.003) revisions and failures on the patient in terms of time
compared with prosthetic grafts. After adjustment for age, race, spent in the hospital, cost, and quality of life is not trivial
side of access placement, and history of prior access placement, [1, 3, 4].patients with a prosthetic graft were estimated to experience
The type of hemodialysis access placed is a criticala 78% increase in the risk of primary access failure when
decision in the management of patients with ESRD. Acompared with similar patients having an autogenous access
[adjusted relative risk (aRR) 5 1.78, 95% CI 1.21–2.62, P 5 number of studies have shown that mature arteriovenous
0.003)]. Similarly, the adjusted relative risk of secondary access fistulas (AVFs) have superior performance when com-
failure for comparing prosthetic grafts with autogenous fistulas pared with prosthetic bridge grafts in terms of patencywas estimated to be 2.21 (95% CI 1.38–3.54, P 5 0.001). The
rates and incidence of infection [2, 5–11]. Despite dataadjusted risk of access revision was 2.89-fold higher for pros-
supporting the preferential placement of AVFs overthetic grafts than for autogenous fistulas (95% CI 1.88–4.44,
P , 0.001). prosthetic grafts, the number of synthetic grafts placed
Conclusions. Autogenous conduits demonstrated superior in the United States relative to AVFs has been increasing
performance when compared with prosthetic grafts in terms [11–13]. The high rate of maturation failure of the radio-
cephalic fistula (13 to 70%) [14–17], late referral to sur-
geons, timing of dialysis, the economics related to accessKey words: vascular access, access patency, dialysis access, autogenous
condiuts, graft patency, fistulas. type, and the inadequacy of veins for wrist AVFs have
all been implicated in the preferential placement of pros-Received for publication November 3, 1999
thetic grafts [2, 11, 12].and in revised form November 28, 2000
Accepted for publication January 11, 2001 Alternative methods of AVF creation, such as brachio-
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transposition, as first described by Dagher et al in 1976 1995, to December 31, 1998 (“late”). These groups were
divided according to a policy change at our institution[18], offer viable alternatives for dialysis in patients with
anatomy not amenable for a radiocephalic AVF. Recent in 1996 emphasizing the placement of autogenous fistulas
rather than prosthetic grafts. A small group (N 5 14) ofstudies have shown that basilic vein transposition offers
excellent patency, a low rate of complications, and matu- patients had no follow-up available beyond the time of
access placement. These patients were used for the com-ration rates that are in general higher than those for
radiocephalic fistulas [5, 7, 17, 19–24]. parison of demographic variables and operative details
among the two cohorts, but were not included in theThe evidence supporting the use of autogenous rather
than prosthetic conduit for dialysis access led to a pol- longitudinal data analysis.
Time to primary access patency was defined as theicy shift at the VA Puget Sound Health Care System
(VAPSHCS). Prior to 1996, prosthetic grafts were gener- length of time between access placement and either per-
manent failure or first revision requiring a surgical orally placed in patients not felt to be candidates for radio-
cephalic fistulae. After 1996, a concerted effort was made radiologic procedure, with restoration of access function
following that procedure. Time to secondary access pat-to use autogenous conduit whenever possible. This policy
included early patient referral for access placement, in- ency was defined as the length of time between access
placement and permanent failure of the access. Failurecreasing use of preoperative duplex scanning to identify
adequate veins, and the use of alternative techniques of a fistula to mature to the point where it could be used
for dialysis and failure of a patent access to be usedsuch as brachiocephalic fistulas and basilic vein and fore-
arm vein transpositions for patients without favorable for dialysis were considered permanent access failures.
Accesses were censored if the patient died or had aanatomy for a radiocephalic fistula.
The purpose of this study was to examine whether the transplant with a patent access, reached the end of the
study with a patent access, transferred care, stopped dial-increased usage of autogenous conduits in this veteran
patient population resulted in improved access perfor- ysis, or were lost to follow-up.
Baseline comparisons between the cohorts in terms ofmance. We also performed a subgroup analysis to exam-
demographic data, comorbidities, and operative detailsine whether there are identifiable groups of patients for
were made using chi-square analysis tests for binomialwhom the placement of autogenous conduits is particu-
categorical variables and two sample t tests for continuouslarly advantageous.
variables. Graft patency rates were analyzed using the
Kaplan–Meier technique with log-rank testing to com-
METHODS pare patency between groups. The analysis of factors asso-
A retrospective cohort study of all dialysis accesses ciated with primary and secondary access failure was per-
placed at VAPSHCS from January 1, 1993, to December formed using Cox proportional hazards regression models.
31, 1998 was conducted. The accesses were placed by Exploratory analyses and residual diagnostics were used
three board certified vascular surgeons assisted by a vas- to test the validity of the proportional hazards assump-
cular surgery fellow or general surgery resident. Proce- tion and to determine the functional form of covariates.
dures to place peritoneal dialysis catheters or central Tests for proportional hazards confirmed that this as-
venous hemodialysis catheters were excluded. Cases were sumption of the Cox model was met for all regressions
identified using operative logs, and details were entered presented. Factors associated with access revision were
into a computer database. All subsequent surgical and assessed using Poisson regression. Because of the repeated-
radiologic revisions of accesses of patients included in the measures nature of the data (multiple accesses placed per
study were obtained from operative notes and radiology patient), observations were not independent. To achieve
reports. No specific monitoring protocols of access were consistent tests of association in the presence of noninde-
in place in our dialysis center, but a vascular surgeon was pendent data, robust coefficient standard error estimates
notified promptly if there were early indications that an were used in all survival and Poisson regression models
access was failing. Demographic data collected included presented. Covariates presented in all multivariate anal-
patient age, gender, and race (black, white, other). Medi- yses were chosen based primarily on three criteria: (1)
cal data included history of diabetes and peripheral vas- biological plausibility that the covariate may be associ-
cular disease. Operative details included type of access ated with the outcome of interest, (2) whether the covari-
(prosthetic or autogenous) and side of access. Follow- ate may confound the relationship between other pre-
up data included dates of revision or access failure, as dictors and the outcome of interest, and/or (3) whether
well as reasons for revision or failure (thrombosis, failure the covariate exhibited a strong univariate association
to mature, infection, ligation). with the predictor of interest. Stratified analyses were
Patients included in this analysis were subdivided into also conducted in selected subgroups to investigate the
two cohorts, one spanning from January 1, 1993, to De- consistency of the effect of access type on primary pat-
ency, secondary patency, and the rate of access revision.cember 31, 1995 (“early”), and the second from January 1,
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Table 1. Characteristics of the study population (N 5 152 patients) before documentation of maturation (2%). In the old
cohort, this rate was 18.4%, while in the new cohort, itCharacteristic Mean 6 SD or N (%)
was 24.7% (P 5 0.440).Demographics
Age years 56.0612.7
Male gender 149 (97.7%) Primary access failure
Non-white race 71 (46.4%)
Kaplan–Meier estimates of cumulative primary pat-Comorbidities
Diabetes 72 (47.3%) ency at one and two years were 36 and 11%, respectively,
PVD 21 (14.0%) for synthetic grafts (Fig. 2). Cumulative primary patency
Operative details
for autogenous fistulas at one and two years was esti-Accesses placed 222
New cohort 118 (53.2%) mated to be 56 and 41%, respectively. A log-rank test
Autogenous access 130 (58.6%) of equality of survival curves verified a significant differ-
Lower arm access 115 (51.8%)
ence in the primary patency rates associated with accessLeft-sided access 160 (72.1%)
First access 125 (56.3%) type (P 5 0.001). Figure 3 shows the secondary access
patency rates.PVD is peripheral vascular disease.
Univariate analysis estimates of the association be-
tween selected covariates and primary access failure are
presented in the first column of Table 2. Prior to adjust-
RESULTS
ment for possible confounders and other predictors of
Population characteristics interest, it was found that younger age, black race, pros-
thetic access use, access placement on the right side ofFrom January 1, 1993, to December 31, 1998, 222
new dialysis accesses were placed in 152 patients at the the body, and a history of previous access placement
significantly increased the risk of primary access failureVAPSHCS. In the early cohort, 104 accesses were
placed, and in the later cohort, 118 accesses were placed. (P , 0.01 for each covariate). The presence of diabetes,
cohort membership, and the year in which the accessTable 1 shows the characteristics of the study population,
including demographic data, comorbidities, type of ac- was placed were not found to be significantly associated
with primary access failure in the univariate analysis.cess placed, and operative details.
Multivariate analysis estimates of the association be-
Trends in access placement tween predictors of interest and primary access failure
are reported in the first column of Table 3. After adjust-During the study period, 92 prosthetic grafts were
placed, and 130 autogenous conduits were created. Fig- ment for race, type of access, side of access placement,
and history of prior access placement, it was estimatedure 1 shows the temporal trend in type of access placed:
The trend toward preferential placement of autogenous that the risk of primary access failure decreased 26%
with each 10-year increase in age [adjusted relative riskfistulas over prosthetic grafts is shown, as 11.1% of ac-
cesses placed in 1993 were autogenous fistulas compared (aRR) 5 0.74, 95% CI 0.62–0.89, P 5 0.001]. Holding
other adjustment variables constant, patients of blackto 94.9% in 1998 (P , 0.001). The figure also shows that
the percentage of accesses created with a vein transposi- ethnicity were estimated to experience a 92% increase
in the risk of primary access failure when compared withtion technique increased with each year of the study
period. There were no significant differences in demo- patients of nonblack ethnicity (aRR 5 1.92, 95% CI
1.13–3.26, P 5 0.016). Patients with a prosthetic accessgraphic variables or comorbidities between the two co-
horts. were estimated to experience a 78% increase in the risk
of primary access failure when compared with similar
Longitudinal follow-up patients having an autogenous access (aRR 5 1.78, 95%
CI 1.21–2.62, P 5 0.003). The estimated risk of primaryFollow-up in the longitudinal group per access (N 5
208) ranged from 4 days to 5.7 years with a mean follow- failure for patients with right-side access placement was
nearly twice as large as that in patients with left-sideup time of 1.4 years. During the course of the study,
32 patients died (23%); 5 received kidney transplants access placement (aRR 5 1.94, 95% CI 1.28–2.93, P 5
0.002). After adjustment, patients with no history of prior(3.6%), and 1 changed modality to peritoneal dialysis
(0.7%). Sixteen patients (12%) were lost to follow-up access placement were estimated to experience a 40%
decrease in the risk of primary failure when comparedduring the study period.
For autogenous fistulas with follow-up, 22.8% were with patients that had at least one access previously
placed (aRR 5 0.60, 95% CI 0.37–0.98, P 5 0.040).never used for dialysis for the following reasons: failure
to mature to usable size (9%), thrombosis prior to first To explore whether the effect of access type on pri-
mary access failure varied in patients with different de-dialysis (4%), death of the patient (2%), ligation of the
fistula for steal (1%), end of the study period prior to mographic, comorbidity, and operative measurements,
selected subgroup analysis estimates of the relative riskmaturation (4%), or loss of follow-up of the patient
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Fig. 1. Temporal trends in type of access
placed. Symbols are: (h) simple fistula; ( )
vein transposition; (j) prosthetic graft.
Fig. 2. Primary patency Kaplan–Meier curve
for all autogenous fistulas (j), matured fistu-
las (r), and prosthetic grafts (m). The number
of patients followed is indicated along the ho-
rizontal axis.
of primary access failure associated with access type are were not found in the diabetic, side of access placement,
history of prior access placement, or cohort subgroups.presented in Figure 4. The largest differences in the effect
of access type on primary failure were witnessed when Ninety-five percent confidence intervals for the effect of
access type on primary failure in all subgroups over-comparing patients younger than 56 years to those 56
years or older and when comparing nonblack ethnicity lapped the interval (1.5–2.3).
to black ethnicity. The estimated relative risk of primary
Secondary access failureaccess failure comparing prosthetic grafts to autogenous
fistulas in patients less than 56 years of age was 2.47 Kaplan–Meier estimates of cumulative primary pat-
(95% CI 1.5–4.2) compared with 1.40 in patients 56 years ency at one and two years were 58 and 41%, respectively,
for synthetic grafts. Cumulative primary patency for au-of age and older (95% CI 0.6–3.2). In patients with non-
black ethnicity, it was estimated that the relative risk of togenous fistulas at one and two years was estimated to
be 72 and 61%, respectively. A log-rank test of equalityprimary failure when comparing grafts to fistulas was
2.68 (95% CI 1.5–4.7) compared with 1.22 in patients of survival curves verified a significant difference in the
primary patency rates associated with access type (P 5with black ethnicity (95% CI 0.7–2.3). Noticeable differ-
ences in the effect of access type on primary access failure 0.003).
Gibson et al: Reduction in prosthetic vascular access 2339
Fig. 3. Secondary patency Kaplan–Meier curve
for all autogenous fistulas (j), matured fistu-
las (r), and prosthetic grafts (m). The number
of patients followed is indicated along the ho-
rizontal axis.
Table 2. Univariate analysis of factors associated with primary and secondary access failure and revision
Outcome
Primary access failure Secondary access failure Access revision
RRb of failure RRb of failure IRRc for revision
Covariate N a (95% CI) P value (95% CI) P value (95% CI) P value
Demographics
Age 10-year increase 208 0.72 (0.57, 0.91) 0.005 0.80 (0.62, 1.04) 0.094 0.83 (0.63, 1.09) 0.185
Race black vs. nonblack 208 2.32 (1.36, 3.94) 0.002 2.33 (1.25, 4.33) 0.008 2.18 (1.26, 3.80) 0.006
Comorbidities
Diabetes yes vs. no 199 0.75 (0.44, 1.28) 0.292 0.79 (0.41, 1.52) 0.486 0.75 (0.41, 1.37) 0.350
Operative details
Type of access prosthetic vs. autogenous 208 2.01 (1.34, 3.02) 0.001 2.27 (1.44, 3.56) ,0.001 3.04 (1.99, 4.66) ,0.001
Location of access 201
Upper arm 1.0 1.0 1.0
Lower arm 1.26 (0.80, 1.97) 0.317 1.28 (0.74, 2.22) 0.368 1.22 (0.75, 1.97) 0.419
Leg 4.49 (1.99, 10.2) ,0.001 3.12 (0.84, 11.6) 0.090 3.58 (1.41, 9.11) 0.007
Side of access right vs. left 207 2.07 (1.25, 3.45) 0.005 1.34 (0.79, 2.28) 0.284 1.48 (0.90, 2.43) 0.125
First access vs. redo 205 0.37 (0.23, 0.58) ,0.001 0.49 (0.28, 0.85) 0.012 0.47 (0.28, 0.78) 0.004
Temporal trends
Cohort new vs. old 208 1.05 (0.63, 1.73) 0.852 0.98 (0.52, 1.83) 0.941 0.87 (0.49, 1.53) 0.618
Time of placement 1-year increase 208 0.90 (0.78, 1.03) 0.135 0.87 (0.73, 1.03) 0.116 0.90 (0.75, 1.07) 0.224
a Number of unique dialysis accesses observed
b Estimated relative risk and 95% CI
c Estimated incidence rate ratio and 95% CI
Univariate analysis estimates of the association be- failure (P 5 0.094). The presence of diabetes, side of
access placement, cohort membership, and the year intween selected covariates and secondary access failure
are presented in the second column of Table 2. Black which the access was placed were not found to be signifi-
cantly associated with secondary access failure in theethnicity, prosthetic access use, and a history of previous
access placement were all found to significantly increase univariate analysis.
Multivariate analysis estimates of the association be-the risk of secondary access failure prior to adjustment
for other covariates of interest (P , 0.05 for each covari- tween predictors of interest and secondary access failure
are reported in the second column of Table 3. Afterate). Younger age was found to have a moderately sig-
nificant association with an increased risk of secondary adjustment for race and type of access, it was estimated
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Table 3. Multivariate analysis of factors associated with primary and secondary access failure and revision
Outcome
Primary access failure Secondary access failure Access revision
RRb of failure RRb of failure IRRc for revision
Covariate N a (95% CI) P value (95% CI) P value (95% CI) P value
Demographics
Age 10-year increase 208 0.74 (0.62, 0.89) 0.001 0.77 (0.62, 0.95) 0.016 0.81 (0.67, 0.98) 0.032
Race black vs. nonblack 208 1.92 (1.13, 3.26) 0.016 2.18 (1.18, 4.05) 0.013 1.74 (1.01, 2.98) 0.045
Operative details
Type of access prosthetic vs. autogenous 208 1.78 (1.21, 2.62) 0.003 2.21 (1.38, 3.54) 0.001 2.89 (1.88, 4.44) ,0.001
Side of access right vs. left 207 1.94 (1.28, 2.93) 0.002 Not included 1.38 (0.99, 1.92) 0.059
Prior access no vs. yes 208 0.60 (0.37, 0.98) 0.040 Not included Not included
a Number of unique dialysis accesses observed
b Estimated relative risk and 95% confidence interval; adjusted for all covariates listed unless noted
c Estimated incidence rate ratio and 95% confidence interval; adjusted for all covariates listed unless noted
Fig. 4. Adjusted relative risk of primary pat-
ency comparing prosthetic grafts to autoge-
nous fistulas in selected subgroups. Relative
risks were adjusted for age, race, side of access
placement, and history of prior access.
that the risk of secondary access failure decreased 23% ative risk estimates of secondary access failure compar-
ing prosthetic grafts to autogenous fistulas in selectedwith each 10-year increase in age (aRR 5 0.77, 95% CI
0.62–0.95, P 5 0.016). Holding other adjustment vari- subgroups are presented in Figure 5. The largest differ-
ences in the effect of access type on secondary failureables constant, patients of black ethnicity were estimated
to experience a more than twofold increase in the risk were witnessed when comparing patients younger than
56 years to those 56 years or older when comparingof secondary access failure when compared with patients
of nonblack ethnicity (aRR 5 2.18, 95% CI 1.18–4.05, nonblack ethnicity to black ethnicity and when compar-
ing left-side access placement to right-side access place-P 5 0.013). Patients with a prosthetic access were esti-
mated to experience a 2.21-fold increase in the risk of ment. The estimated relative risk of secondary access
failure comparing prosthetic grafts to autogenous fistulassecondary access failure when compared with similar
patients having an autogenous access (aRR 5 2.21, 95% in patients less than 56 years of age was 3.15 (95% CI
1.8–5.7) compared with 1.60 in patients 56 years of ageCI 1.38–3.54, P 5 0.001).
Subgroup analyses were again conducted in order to and older (95% CI 0.6–4.3). In patients with nonblack
ethnicity, it was estimated that the relative risk of second-explore whether the effect of access type on secondary
access failure varied in patients with different demo- ary failure when comparing grafts to fistulas was 3.47
(95% CI 1.8–6.9) compared with 1.76 in patients withgraphic, comorbidity, and operative measurements. Rel-
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Fig. 5. Adjusted relative risk of secondary
patency comparing prosthetic grafts to autog-
enous fistulas in selected subgroups. Relative
risks were adjusted for age and race.
black ethnicity (95% CI 0.9–3.6). In patients with a left- adjusted incidence rate ratio (aIRR) (aIRR 5 0.67, 95%
CI, 0.67, 0.98, P 5 0.032). Holding other adjustmentside access placement, it was estimated that the relative
risk of secondary access failure when comparing grafts variables constant, patients of black ethnicity were esti-
mated to experience a 74% increase in the risk of accessto fistulas was 1.89 (95% CI 1.0–3.5) compared with 3.40
in patients with a right-side access placement (95% CI revision when compared with patients of nonblack eth-
1.6–7.5). Noticeable differences in the effect of access nicity (aRR 5 1.74, 95% CI 1.01–2.98, P 5 0.045). Pa-
type on secondary access failure were not found in the tients with a prosthetic access were estimated to experi-
diabetic, history of prior access placement, or cohort ence almost a threefold increase in the risk of access
subgroups. Ninety-five–percent confidence intervals for revision when compared with similar patients having an
the effect of access type on secondary failure in all sub- autogenous access (aRR 5 2.89, 95% CI 1.88–4.44, P ,
groups overlapped the interval (1.8–3.5). 0.001). After adjustment, the estimated risk of access
revision for patients with right-side access placement was
Access revision 38% higher than that in patients with left-side access
placement (aRR 5 1.38, 95% CI 0.99–1.92, P 5 0.059).Univariate analysis estimates of the association be-
tween selected covariates and the rate of access revision Incidence rate ratio estimates of access revision com-
paring prosthetic grafts to autogenous fistulas in selectedare presented in the third column of Table 2. Prior to
adjustment for possible confounders and other pre- subgroups are presented in Figure 6. Similar to the sub-
group findings for secondary access failure, the largestdictors of interest, it was found that black ethnicity, pros-
thetic access use, and a history of previous access place- differences in the effect of access type on secondary
failure were witnessed when comparing patients youngerment significantly increased the risk access revision (P ,
0.01 for each covariate). Age, the presence of diabetes, than 56 years to those 56 years or older, when comparing
nonblack ethnicity to black ethnicity, and when compar-side of access placement, cohort membership, and the
year in which the access was placed were not found to ing left-side access placement to right-side access place-
ment. The estimated relative risk of access revision com-be significantly associated with the rate of access revision
in the univariate analysis. paring prosthetic grafts to autogenous fistulas in patients
of less than 56 years of age was 3.58 (95% CI 2.1–6.2)Multivariate analysis estimates of the association be-
tween predictors of interest and the rate of access revi- compared with 2.18 in patients 56 years of age and older
(95% CI 1.0–4.7). For patients with nonblack ethnicity,sion are reported in the third column of Table 3. After
adjustment for race, type of access, and side of access it was estimated that the relative risk access revision
when comparing grafts to fistulas was 4.33 (95% CI, 2.3,placement, it was estimated that the risk of access revi-
sion decreased 19% with each 10-year increase in age 8.1) compared with 2.22 for patients with black ethnicity
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Fig. 6. Adjusted rate ratios of access revision
comparing prosthetic grafts to autogenous fis-
tulas in selected subgroups. Relative risks
were adjusted for age, race, and side of access
placement.
(95% CI 1.2–4.0). For patients with a left-side access placement, a meticulous search for usable autogenous
placement, it was estimated that the relative risk of access conduit, including the use of preoperative duplex vein
revision when comparing grafts to fistulas was 2.42 (95% mapping, and an expansion of our repertoire of fistula
CI 1.5–4.0) compared with 4.40 for patients with a right- creation procedures. The radial artery-cephalic vein fis-
side access placement (95% CI 2.4–8.2). Noticeable dif- tula described by Brescia et al remained our preferred
ferences in the effect of access type on access revision access when possible [27]; however, the number of alter-
were not found in the diabetic, history of prior access native procedures for fistula creation, such as basilic vein
placement, or cohort subgroups. Ninety-five–percent transposition, increased over the study period.
confidence intervals for the effect of access type on sec- Although the proportion of fistulas placed increased,
ondary failure in all subgroups overlapped the interval we did not find a statistically higher percentage of fistulas
(2.4–4.0). that were never used for dialysis in the new cohort as
compared with the old cohort. Furthermore, the percent-
age of autogenous fistulas that did mature compares fa-DISCUSSION
vorably with maturation rates quoted in current litera-Our data are consistent with the literature in which
ture of 30 to 85% [8, 14, 15, 17, 28]. Additionally, ourpolicies to increase the percentage of autogenous fistulas
preferential use of autogenous conduit, while differentrelative to prosthetic grafts have resulted in a greater
from patterns seen in the United States, is comparable toproportion of autogenous fistulas placed [25, 26]. As a
trends in Europe where placement of autogenous fistulasresult of our policy change, there was dramatic increase
exceeds 70% and in Japan where it is estimated at 90%in the proportion of autogenous fistulas placed for dial-
[2, 29].ysis access. Fully 95% of the accesses placed in the last
Our data in the study population as a whole show thatyear of the study were autogenous fistulas, and of these,
autogenous fistulas were superior to prosthetic grafts.18% were vein transpositions. This shift in type of access
Both primary and secondary patency were superior inplaced contrasts with nationwide trends in which the
autogenous fistulas. The rate of infection was dramati-percentage of prosthetic access placed has been increas-
cally lower, and the incidence of revisions per access pering in relationship to autogenous fistulas [2] and in our
year was markedly decreased. Although some studiesregional trends in which the percentage of prosthetic
have shown no superiority of autogenous fistulas in termsgrafts has remained unchanged (personal communica-
of primary and secondary patency [14, 28], most supporttion, U.S. Renal Data System). Our ability to place au-
our position that autogenous fistulas are superior to pros-togenous fistulas in the majority of our patients was likely
thetic grafts [5–10, 30]. Additionally, many studies com-due to several factors: an effort on the part of nephrolo-
gists at our institution to refer patients early for access paring prosthetic grafts to autogenous fistulas do not
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examine rates of revision, an important factor in terms sions than other races. This difference persisted even
when controlling for comorbid factors and age. In addi-of economics, number of hospitalizations, and overall
patient quality of life. tion, although all patients had superior primary and sec-
ondary patency and fewer revisions after receiving autog-While the patency rates in autogenous fistulas in this
study are comparable to other reported rates, the perfor- enous accesses compared with prosthetic accesses, the
magnitude of this benefit was less among black patientsmance of prosthetic access was inferior to that described
by other authors, particularly in terms of primary patency than among nonblack patients. This may explain incon-
sistencies in reports from several authors in which some[3, 5–7]. The reason for the suboptimal performance of
prosthetic grafts in this series is not clear, but may be have found that black patients have a higher rate of hospi-
talizations for access-related morbidity [3, 36], while oth-biased by a small number of patients in the study who had
very poor outcomes with their access, having multiple ers have found no difference in patency rates and fistula
performance between blacks and nonblacks [15, 34]. Theprosthetic accesses placed and multiple early revisions.
The patency of prosthetic grafts was especially poor in reason for the poorer outcome of fistulas in our black
population is unclear. Whether our findings are due tothe later part of the study, which further decreased our
overall reported patency rates. This decrease in pros- sociologic or physiologic factors was not within the scope
of this study.thetic graft patency was most likely a result of our policy
emphasizing placement of autogenous fistulas, as only Comparison of history of prior access (first access vs.
previous access) showed that first accesses had superiorpatients with very poor venous anatomy had placement
of the synthetic conduit. Patients with prosthetic graft primary patency and lesser risk of revision in the univari-
ate analysis. In addition, although a superiority of autog-placement also were more likely to have had multiple
previously failed accesses later in the study. enous access compared with prosthetic accesses was seen
among first and subsequent accesses, the magnitude wasA widespread belief that older patients with ESRD
are not good candidates for autogenous fistulas may con- greater among first accesses with regard to primary and
secondary patency. Autogenous first access was also su-tribute to the lower rate of fistula placement in older
patients. Studies have demonstrated that older patients perior to subsequent access with regard to the incidence
of revision. Both first and subsequent autogenous ac-are more likely to have a prosthetic graft placed [13, 31].
We were able to place autogenous fistulas in 78% of our cesses had lower revision rates than prosthetic accesses.
This suggests that among patients with previous pros-older patients in the later cohort. While many older
patients may have inadequate forearm veins for autoge- thetic access failures, placement of an autogenous fistula
rather than another prosthetic graft may reduce the num-nous fistula creation, a diligent search for alternative
possibilities, such as utilizing the upper arm vein, should ber of revisions necessary to maintain a patent access.
Among prosthetic accesses, primary patency and inci-make use of the autogenous tissue possible. A recent
publication by Berardinelli and Vegeto suggests that up- dence rate of revision were superior among patients with
left-sided accesses. Both right- and left-sided autogenousper arm fistulas may be the access of choice in older
patients [32]. accesses performed better than prosthetic grafts with
regard to patency and rate of revision, although right-The selection of vascular access type in older patients
is an important yet controversial issue. In 1997, fully sided autogenous accesses tended to demonstrate a
greater advantage than left-sided autogenous accesses.51% of the incident chronic hemodialysis population was
greater than 65 years old [33]. This percentage is likely The reason for this finding is not readily apparent, but
may relate to the number of prior accesses the patientsto increase as the United States population continues to
age and as the willingness to offer dialysis to older pa- have had. In our population, 70% of the accesses were
placed on the left side and 30% on the right. Assumingtients increases [31]. A number of studies have shown
that autogenous fistulas have poorer patency rates in that first attempts at accesses would be placed in the
nondominant arm and 90% of the population is right-older patients [15, 29, 30, 34], and some authors have
suggested that autogenous fistulas may not be the initial hand dominant, most right-sided accesses were likely
placed in patients in whom sites for access on the left sideaccess of choice in some older patients [15]. Other au-
thors have found either no effect of age on access survival had been exhausted. Because data were not complete on
the number of previous accesses in our patients (manyor improved overall access survival in older patients
[9, 35]. Although we found overall improved access sur- had accesses placed at other institutions or before the
study period), this was not assessed in the analysis. In avival among older patients, subgroup analyses revealed
that the benefit of placing autogenous fistulas in older subgroup of our population (N 5 175) for whom com-
plete records existed on the number of prior accesses,patients may not be as large as that attained by placement
of fistulas in younger patients. multivariate analysis did not reveal the side of access to
be a factor for failure or revision.In our analysis, black ethnicity was associated with
poorer primary and secondary patency and more revi- When analyzing differences between the two study
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